GLP-1 Drugs Beyond Weight Loss

North Dakota State University and Sanford Health are launching a major $210K research initiative to uncover how GLP-1 weight-loss drugs impact health beyond just weight loss—tracking body composition, mobility, substance use, mental well-being, and healthcare utilization. Enrollment opens late July; this multi-institutional effort brings together Fargo, Sioux Falls, and NDSU’s Center for Advancement in Pharmacy to decode the full clinical picture of these drugs. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/f55f7a3dfac2e767